Kehua Biotech (002022.SZ) announced that the company received the “Medical Device Note...” issued by the Shanghai Drug Administration
Zhitong Finance App News, Kehua Biotech (002022.SZ) announced that the company received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. The product name is a leucine aminopeptidase determination kit (L-leucyl p-nitroaniline substrate method), which is used to quantitatively measure the activity of leucine aminopeptidase (LAP) in human serum, plasma or urine samples in vitro. For auxiliary diagnosis.